.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Identify first generic entrants
  • Drug patents and clinical trials in dozens of countries

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Chinese Patent Office
Medtronic
Boehringer Ingelheim
Teva
US Department of Justice
Federal Trade Commission
McKinsey
AstraZeneca
Cipla

Generated: June 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 073665

« Back to Dashboard
NDA 073665 describes ATENOLOL AND CHLORTHALIDONE, which is a drug marketed by Alvogen Malta, Mylan, Nostrum Labs, Pliva, Watson Labs, Mutual Pharm, and Sun Pharm Inds, and is included in eight NDAs. It is available from fifteen suppliers. Additional details are available on the ATENOLOL AND CHLORTHALIDONE profile page.

The generic ingredient in ATENOLOL AND CHLORTHALIDONE is atenolol; chlorthalidone. There are thirty-three drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the atenolol; chlorthalidone profile page.

Summary for NDA: 073665

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 073665

Mechanism of ActionAdrenergic beta-Antagonists
Physiological EffectIncreased Diuresis

Suppliers and Packaging for NDA: 073665

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ATENOLOL AND CHLORTHALIDONE
atenolol; chlorthalidone
TABLET;ORAL 073665 ANDA Actavis Pharma, Inc. 0591-5782 0591-5782-01 100 TABLET in 1 BOTTLE (0591-5782-01)
ATENOLOL AND CHLORTHALIDONE
atenolol; chlorthalidone
TABLET;ORAL 073665 ANDA Actavis Pharma, Inc. 0591-5783 0591-5783-01 100 TABLET in 1 BOTTLE (0591-5783-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG;25MG
Approval Date:Jul 2, 1992TE:ABRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG;25MG
Approval Date:Jul 2, 1992TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Dow
Deloitte
Johnson and Johnson
McKesson
Chinese Patent Office
US Army
Julphar
QuintilesIMS
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot